|
|
|
|
|
|
Celgene Corp (CELG)
|
|
131.38 +0.01 (+0.01%)
|
8/16/2017 1:00pm
|
|
Open:
|
131.77
|
Pre. Close:
|
131.37
|
|
High:
|
132.12
|
Low:
|
130.70
|
|
Volume:
|
1,096,521
|
Market Cap:
|
102.79B
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
134.17 - 135.72
|
135.72 - 136.51
|
|
Low:
|
128.54 - 130.05
|
130.05 - 130.81
|
|
Close:
|
129.62 - 132.04
|
132.04 - 133.27
|
|
|
|
|
|
|
Technical analysis (as of: 2017-08-16 1:08:02 PM)
|
|
Overall:
|
 
|
|
Stoxline posted a NEUTRAL today, upgraded from lower rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.
|
|
Target:
|
Six months: 158.26 One year: 162.35
|
|
Support:
|
Support1: 129.83 Support2: 108.02
|
|
Resistance:
|
Resistance1:
135.50 Resistance2: 139.00
|
|
Pivot:
|
134.07 
|
|
Moving Averages:
|
MA(5): 131.38 MA(20): 134.86
MA(100): 126.37 MA(250): 118.74
|
|
MACD:
|
MACD(12,26):
-0.03 Signal(12,26,9): 0.80
|
|
%K %D:
|
%K(14,3): 23.41 %D(3): 19.80
|
|
RSI:
|
RSI(14): 44.98
|
|
52-Week:
|
High: 139.00
Low: 96.93 Change(%): 17.4
|
|
Average Vol(K):
|
3-Month: 374781
10-Days 191459
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.CELG has closed above bottom band by 20.7%. Bollinger Bands are 6.2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
|
|
|
Headline News
|
|
Tue, 15 Aug 2017 12:00:00 GMT
How do I love thee, Celgene? Let me count the ways.
Thu, 10 Aug 2017 09:56:15 GMT
A Celgene-Ius Investment
Mon, 07 Aug 2017 11:37:30 GMT
Celgene Paves The Way For Rare AML Patients
Sat, 22 Jul 2017 15:33:45 GMT
The case for Gilead Sciences
Tue, 15 Aug 2017 15:56:15 GMT
Plaintiffs Firm Sues for Fees in Celgene $280M Settlement
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
